Pharma Companies in Karnal: Directory & 2026 Update

Last verified: July 2026

If you’re searching for a pharma company in Karnal — to place an order, verify a supplier, scope out a PCD franchise partner, or find a third-party manufacturer — you probably don’t want a history lesson first. So here’s the directory up front, followed by the industrial-area breakdown, the honest state of the Karnal Pharma Park project, and what any of this means if you’re evaluating Karnal as a place to buy, build, or expand.

I’ve worked QC, QA, and regulatory affairs in this industry for 23 years, much of it within reach of Karnal’s industrial areas. What follows is written from that vantage point — not a summarized survey.

Pharma Companies in Karnal — Directory

The interactive, searchable version of this table is embedded below (or linked, depending on your placement). This is a partial, representative list compiled from Laafon Galaxy’s own business records and public company directories — it is not exhaustive. Karnal has an estimated 60+ pharma-adjacent manufacturing units; verify current operating status, licensing, and address before doing business with any company you don’t already know.

Don’t see a company you’re looking for, or notice an error? Let us know — we keep this list current based on reader and industry feedback.

Karnal’s Real Advantage: Infrastructure, Not Announcements

Karnal’s pharma cluster didn’t grow because of a government project — it grew because of geography and an ecosystem that’s been compounding since the mid-1990s, and that’s still the strongest reason to look at Karnal today.

Location. Karnal sits on NH-1, roughly 125 km from Delhi (2–3 hours by road) and about 130 km from Chandigarh. For a manufacturer or PCD franchise partner whose primary market is Delhi-NCR, that’s a genuine logistics advantage over hubs like Baddi or Sikkim that are built around excise-exemption history rather than proximity to market.

Raw materials and packaging. Bulk drug and raw-material suppliers have operated in Karnal since the mid-1990s, and the packaging-materials industry locally dates to around 1990 — blister packs, bottles, cartons, and printing/labeling services are all available without shipping in from Delhi or Baddi. Karnal is also home to a sizeable cluster of PET bottle manufacturers (concentrated in the Mughal Majra industrial area) and nutraceutical/protein-powder can manufacturers, which matters if your product line touches either category.

Established manufacturing base. Karnal has been a recognized pharmaceutical manufacturing location since the mid-1990s. There were reportedly 40+ manufacturing companies operating here around 2005, before Himachal Pradesh and Uttarakhand’s excise-free zones drew some investment away. As of this writing, an estimated 60+ pharma manufacturing and third-party units are active in and around the city — a figure that circulates locally rather than one confirmed by a single published census, so treat it as an informed estimate rather than an official count.

Industrial Areas in Karnal

The filterable version of this section is in the second interactive component below.

• ITI Chowk (Kunjpura Road) — opposite the power house; one of Karnal’s older established industrial pockets.
• HSIIDC Sector-3 — home to several of Karnal’s established manufacturers, including Zee Laboratories and Cure Quick Pharmaceuticals.
• HSIIDC Sector-3, Part-2 — a newer, developing extension of Sector-3.
• HSIIDC Sector-36 — Karnal’s largest industrial area.
• Meerut Road (opposite the sugar mills) — one of Karnal’s older industrial zones.
• Mughal Majra — a fast-developing cluster, notably concentrated with PET bottle manufacturers and pharma-adjacent packaging units.
• Kunjpura — home to a number of plastic container manufacturers.
• Taraori — on NH-1, with rail connectivity; historically better known as a basmati rice and Hafed grain-storage hub than a pharma zone, but it’s the proposed site for the Karnal Pharma Park (see below).

The Karnal Pharma Park (KPPL): What’s Actually Confirmed, as of July 2026

This is the section most competing content gets wrong — either by repeating the original launch announcement as current news, or ignoring it entirely. Here’s what’s verifiable and what isn’t.

What was announced: The Haryana government proposed a pharma hub in Taraori, on NH-1, to be developed on 100 acres with infrastructure built out by HSIIDC. The special purpose vehicle behind it, Karnal Pharma Park Ltd. (KPPL), was reported at the time to have around 45 manufacturers and marketers signed on as members. R.L. Sharma, identified as KPPL’s SPV chairman, was quoted estimating the project would attract roughly Rs. 2,000 crore in investment once fully operational and generate around 25,000 jobs, with an original completion estimate of about two years from announcement.

What we can confirm as of July 2026: We have not found independent, published confirmation — from HSIIDC, Haryana government sources, or news coverage — of physical construction progress, a revised completion timeline, allotment status, or updated investment figures for this project. The claims above trace back to the original announcement and have not been independently re-verified since.

What this means for you: If the Pharma Park’s Common Facility Centre, subsidized testing, or single-window clearance are factoring into your decision to set up in Karnal, verify current status directly with HSIIDC or Haryana’s Industries & Commerce Department before you plan around it. Don’t take our word, or anyone else’s recycled version of the original announcement, as confirmation that ground has been broken.

We’ll update this section if and when we can confirm on-the-ground progress.

Third-Party Manufacturing and PCD Franchise in Karnal

Two business models dominate how companies without their own manufacturing footprint operate in Karnal:

Third-party (contract) manufacturing: A brand-owning company contracts a certified local manufacturer to produce medicines to its own formulation specifications, packaged under the brand company’s own label. The manufacturer bears production and quality responsibility; the brand company handles sales, marketing, and distribution. For a company entering the market, this typically means a much smaller capital outlay than building a facility, and a faster path to having product in hand.

PCD (Propaganda Cum Distribution) franchise: A parent company grants a franchise partner exclusive distribution rights for specific products in a defined territory, along with marketing materials and product training. This is generally the lowest-capital entry point into pharma distribution, though territory, minimum order requirements, and contract terms vary by parent company — get these specifics in writing before committing.

Karnal has an established base of both third-party manufacturers and PCD-focused companies (see the directory above), built up over nearly three decades, which is a meaningfully different starting position than a cluster trying to attract this business from scratch.

Where Laafon Galaxy fits: Laafon Galaxy Pharmaceuticals is itself based in Karnal and offers third-party manufacturing and PCD franchise services, along with regulatory affairs and compliance support. If you’re evaluating Karnal as a manufacturing or franchise partner location, our current plant listings and PCD franchise page cover live opportunities in Karnal and the wider Haryana/HP/UK region — worth a look alongside the directory above, not instead of it.

Regulatory Basics: DCGI Licensing and WHO-GMP

Anyone evaluating a Karnal-based manufacturer, or planning to set up here, should understand two separate things: the legal license to manufacture, and the voluntary quality certification.

DCGI drug manufacturing license (via CDSCO) is the legal requirement to manufacture — Form 25 for non-Schedule drugs (tablets, capsules, non-sterile syrups), Form 28 for Schedule C/C1 drugs (injectables, biologics, hormones, which require aseptic processing capability), and Form 29 as a temporary loan license. Operating without this is a criminal offense, not a compliance nuance.

WHO-GMP certification is not a license — it’s a voluntary quality standard that signals a manufacturer meets international Good Manufacturing Practice benchmarks. It matters commercially because it’s typically a prerequisite for exporting into WHO-prequalified and many regulated markets, and it’s a reasonable due-diligence check when you’re vetting a Karnal manufacturer as a partner: ask to see current WHO-GMP or GMP certification directly rather than taking a company’s own claim at face value.

Schedule M note: The Drugs and Cosmetics Rules’ revised Schedule M — aligning domestic GMP requirements more closely with WHO-GMP — has been in a phased enforcement rollout; if you’re vetting a manufacturer’s compliance status, ask specifically where they stand on revised Schedule M implementation rather than relying on older GMP claims alone, since requirements have tightened.

(We’re deliberately not publishing an exact count of “how many Karnal units hold WHO-GMP certification” here — we found this number quoted with false precision elsewhere and couldn’t independently verify it. Ask any individual manufacturer for their current certificate directly.)

Frequently Asked Questions

A Note on This Update

This page previously included specific figures — exact industry turnover, a multi-year growth projection table, phase-by-phase investment breakdowns for the Pharma Park, and precise WHO-GMP unit counts — that we could not independently verify against any published source as of July 2026. We’ve removed or replaced them with what we could actually confirm, and dated the claims that remain. If you have current, sourceable data on any of these (an official HSIIDC update, a recent news report, a government notification), we’d genuinely like to update this page with it — reach out via our contact page.